Press releases
- Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
- Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
- Carisma Therapeutics to Present at Upcoming Conferences
- Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
- Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
More ▼
Key statistics
On Friday, Carisma Therapeutics Inc (W2J:BER) closed at 1.53, 2.76% above its 52-week low of 1.49, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.55 |
---|---|
High | 1.58 |
Low | 1.52 |
Bid | 1.43 |
Offer | 1.62 |
Previous close | 1.54 |
Average volume | 0.00 |
---|---|
Shares outstanding | 41.54m |
Free float | 27.95m |
P/E (TTM) | -- |
Market cap | 68.13m USD |
EPS (TTM) | -3.70 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 19:08 BST.
More ▼